Boardroom Alpha
Meeting calendar
LWAY · Annual meeting · Wednesday, June 17, 2026

Lifeway Foods Inc

7 nominees · 3 ballot items.

Elect seven directors to the Board; ratify Grant Thornton LLP as independent auditor for fiscal year 2026; and approve, on a non-binding advisory basis, the compensation of the named executive officers (Say-on-Pay).

Market cap
$488M
1Y TSR
+17.4%
Board grade
C
Record date
Apr 20, 2026
Filing
DEF 14A
Meeting concluded · Jun 17, 2026

Follow how the vote landed and what changed on Lifeway Foods Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect seven (7) nominees (Kirk Chartier, Juan Carlos (JC) Dalto, Rachel Drori, Andee Harris, Susie Hultquist, Dorri McWhorter, and Julie Smolyansky) to serve on Lifeway’s Board until the 2027 Annual Meeting (or until successors are elected and qualified).

  2. 2

    Ratify Grant Thornton LLP as our independent auditor for fiscal year 2026

    ManagementBoard: FOR

    Ratify the Audit and Corporate Governance Committee’s appointment of Grant Thornton LLP as Lifeway’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

  3. 3

    Non-binding advisory vote on executive compensation (Say-on-Pay

    ManagementBoard: FOR

    A non-binding, advisory vote to approve the compensation paid to the Company’s named executive officers as disclosed in the proxy statement.

    More detail

    This proposal asks shareholders to cast a non-binding advisory vote approving the compensation of Lifeway’s named executive officers as disclosed in the proxy. Management seeks this advisory approval as part of routine corporate governance and shareholder engagement practices and to solicit shareholder feedback on pay practices. The filing documents historical context: the prior say-on-pay support fell from 58.5% in 2024 to 53.3% in 2025, prompting enhanced shareholder engagement by the Compensation Committee and management. The Company describes substantial changes and constraints affecting compensation, most notably the Cooperation Agreement with Danone which limits the Company’s ability to grant equity to the CEO and certain family-affiliated employees unless Danone consents; as a result, the Board has sometimes settled the CEO’s awards in cash to preserve total target pay. The Compensation Committee also reconstituted its membership to include a majority of New Independent Board Members, enabling broader use of equity for management (other than the CEO and certain affiliates) consistent with market practices. Lifeway explains its pay design: a mix of base salary, short-term cash incentives tied to Adjusted EBITDA and Net Revenue, and long-term incentives composed of PSUs (measured on 3‑year cumulative revenue and cumulative Adjusted EBITDA) and RSUs, with performance thresholds and a defined vesting schedule. Management emphasizes that recent strong company performance (e.g., actual 2025 Adjusted EBITDA and Net Revenue above targets, leading to maximum payouts) supports the reasonableness of pay outcomes. The Board recommends voting FOR the proposal while noting the vote is advisory and that the Compensation Committee will consider shareholder feedback in future compensation decisions. This summary should be evaluated in context of Lifeway’s ownership concentration (major insiders and Danone control large blocks) and contractual constraints that materially affect how and to whom equity can be granted, which are central to the governance tradeoffs underlying pay decisions.

Director elections

Nominees on the ballot7

Independent
Tenure on this board
6.0 yrs
Also a director at
Lanzatech Global Inc (LNZA)
Ownership

Top institutional holders10

Latest 13F quarter
1Divisadero Street Capital Management, LP9.2%1,408,768$27M
2Cresset Asset Management, LLC3.3%508,232$10M
3RENAISSANCE TECHNOLOGIES LLC2.4%368,671$7M
4TUDOR INVESTMENT CORP ET AL1.7%266,398$5M
5VANGUARD CAPITAL MANAGEMENT LLC1.7%262,061$5M
6DIMENSIONAL FUND ADVISORS LP1.4%215,453$4M
7GAMCO INVESTORS, INC. ET AL1.4%214,650$4M
8BlackRock, Inc.1.2%181,341$4M
9Slotnik Capital, LLC1.0%157,473$3M
10TWO SIGMA INVESTMENTS, LP0.8%119,629$2M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Lifeway Foods Inc 2026 annual meeting?
Lifeway Foods Inc (LWAY) holds its 2026 annual shareholder meeting on Wednesday, June 17, 2026.
What is the record date for the Lifeway Foods Inc 2026 meeting?
The record date for the Lifeway Foods Inc 2026 meeting is Monday, April 20, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Lifeway Foods Inc's 2026 meeting?
The board is presenting 7 director nominees at the Lifeway Foods Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Lifeway Foods Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Lifeway Foods Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer